+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneus Ltd - logo

Founded in 2007, Regeneus are a Sydney-based regenerative medicine company developing a portfolio of innovative cell-based therapies, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms.The company has two product candidates in Phase 1 trials for humans, Progenza and RGSH4K. Regeneus is headquartered in New South Wales, Australia.

From
Mesenchymal Stem Cells - Advances & Applications, 2019 - Product Thumbnail Image

Mesenchymal Stem Cells - Advances & Applications, 2019

  • Report
  • October 2019
  • 224 Pages
From
From
From
From
From
From
From
Delving into Stem Cell Research and its Potential 2018 - Product Thumbnail Image

Delving into Stem Cell Research and its Potential 2018

  • Report
  • December 2018
  • 155 Pages
From
Osteoarthritis - Pipeline Review, H1 2020 - Product Thumbnail Image

Osteoarthritis - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 345 Pages
From
Neuropathic Pain - Pipeline Review, H2 2019 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 838 Pages
From
From
From
From
Loading Indicator
adroll